1-(4-amino-5-chloro-2-methoxyphenyl)-3-[1-(cycloheptylmethyl)-4-piperidinyl]propan-1-one fumarate salt – Pharmaceutical composition and associated uses

FR3166146A1Pending Publication Date: 2026-03-13UNIV CAEN
2 Cites 0 Cited by

Patent Information

Authority / Receiving Office
FR · FR
Patent Type
Applications
Current Assignee / Owner
Filing Date
2024-09-12
Publication Date
2026-03-13
Patent Text Reader

Abstract

1-(4-amino-5-chloro-2-methoxyphenyl)-3-[1-(cycloheptylmethyl)-4-piperidinyl]propan-1-one fumarate salt – Pharmaceutical composition and associated use. The present invention relates to a compound selected from the fumarate salt of 1-(4-amino-5-chloro-2-methoxyphenyl)-3-[1-(cycloheptylmethyl)-4-piperidinyl]propan-1-one, and the hydrates of this salt, said compound being in particular in the crystalline solid state. The present invention also relates to a pharmaceutical composition, comprising as a pharmaceutically active ingredient the compound of the invention, as well as the compound of the invention for its use as a medicament and in particular for its use in the treatment of a neurodegenerative disease selected in particular from Alzheimer's disease and Parkinson's disease. Figure for the abstract: None
Need to check novelty before this filing date? Find Prior Art

Citation Information

Patent Citations

  • Acetylcholinesterase inhibitor compounds and 5ht4 serotonergic receptor agonists, with promnesia effect, methods for the preparation thereof and pharmaceutical compositions containing same

    WO2014195593A2

  • Donecopride as neuroprotective agent in the treatment of neurodegenerative diseases

    WO2020065028A1